Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews.
暂无分享,去创建一个
Lawrence Mbuagbaw | Tamara Kredo | Vivian Welch | V. Welch | L. Mbuagbaw | T. Kredo | S. Ross | B. Zani | S. Mursleen | N. V. Motaze | Babalwa Zani | Theresa Aves | Stephanie Ross | Sara Mursleen | Nkengafac Villyen Motaze | Leah Quinlan | T. Aves | L. Quinlan | Babalwa Zani
[1] Jeremy Grimshaw,et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. , 2009, Journal of clinical epidemiology.
[2] A. Copas,et al. Factors Associated with HIV Prevalence and HIV Testing in Sierra Leone: Findings from the 2008 Demographic Health Survey , 2015, PloS one.
[3] N. McGrath,et al. The Impact of Gender Norms on Condom Use among HIV-Positive Adults in KwaZulu-Natal, South Africa , 2015, PloS one.
[4] Tim Evans,et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. , 2014, Journal of clinical epidemiology.
[5] Tomas Pantoja,et al. Health equity: evidence synthesis and knowledge translation methods , 2013, Systematic Reviews.
[6] S. Oliver,et al. Health promotion, inequalities and young people’s health: a systematic review of research , 2008 .
[7] M. Eriksson,et al. Access to social capital and risk of HIV infection in Bukoba urban district, Kagera region, Tanzania , 2014, Archives of Public Health.
[8] Tim Evans,et al. Road traffic crashes: operationalizing equity in the context of health sector reform , 2003, Injury control and safety promotion.
[9] V. Welch,et al. Critical EPICOT items were absent in Cochrane human immunodeficiency virus systematic reviews: a bibliometric analysis. , 2016, Journal of clinical epidemiology.
[10] S. Oliver,et al. Reflections on developing and using PROGRESS-Plus , 2008 .
[11] A. Abdul-Quader,et al. Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013. , 2015, MMWR. Morbidity and mortality weekly report.
[12] Nicolas Roussiau,et al. The Role of Mediators in the Indirect Effects of Religiosity on Therapeutic Compliance in African Migrant HIV-Positive Patients , 2016, Journal of Religion and Health.
[13] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[14] N. McGrath,et al. Correction: The Impact of Gender Norms on Condom Use among HIV-Positive Adults in KwaZulu-Natal, South Africa , 2015, PloS one.
[15] H. Weiss,et al. Frequency of HIV-testing and factors associated with multiple lifetime HIV-testing among a rural population of Zambian men , 2015, BMC Public Health.
[16] S. Shade,et al. Implementation and Operational Research: Pulling the Network Together: Quasiexperimental Trial of a Patient-Defined Support Network Intervention for Promoting Engagement in HIV Care and Medication Adherence on Mfangano Island, Kenya , 2015, Journal of acquired immune deficiency syndromes.
[17] P. Tugwell,et al. Does Consideration and Assessment of Effects on Health Equity Affect the Conclusions of Systematic Reviews? A Methodology Study , 2012, PloS one.
[18] C. Kohler,et al. The Relationship Between HIV Risk, High-Risk Behavior, Religiosity, and Spirituality Among Black Men Who Have Sex with Men (MSM): An Exploratory Study , 2016, Journal of Religion and Health.